Dexmedetomidine for Catheter-related Bladder Discomfort
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 114 participants.
Also called NCT01991223
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 114 participants
- Registry
-
NCT01991223
-
- Other papers using this trial's data
- The effect of intraoperative dexmedetomidine on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumour resection: A double-blind randomised study
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01991223. Randomized; double masking; primary purpose prevention. Start 2013-11 (registry gives no type); primary completion 2014-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dexmedetomidine for Catheter-related Bladder Discomfort
- Acronym
- CRBDEX
- Condition
- Pain
- Condition
- Blood Pressure
- Condition
- Nausea
- Condition
- Vomiting
- Condition
- Arrhythmia
- Intervention (Drug)
- Dex infusion
- Intervention (Drug)
- NS infusion
- Lead sponsor
- Seoul National University Hospital
Record details
- Record id
cardio:ct-nct01991223- Content hash
2832a09d22148c383dcec219aa3c600180b1d156317f7096e7ebb0d5bd44e228